Effect of type-I interferon on retroviruses

Viruses

Volumn 1, Issue 3, 2009, Pages 545-573

  Gómez Lucía, Esperanza ^a   Collado, Victorio M ^a   Miró, Guadalupe ^a   Doménech, Ana ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

FeLV; HIV 1; HTLV I; ISRE; MuLV; Retrovirus; Type I interferons

Indexed keywords

EID: 84855750679     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v1030545     Document Type: Review

References (150)

1. Abbate, I.; Dianzani, F.; Capobianchi, M. R. Activation of signal transduction and apoptosis in healthy lymphomonocytes exposed to bystander HIV-1-infected cells. Clin. Exp. Immunol. 2000, 122, 374-380.
2. Aboud, M.; Kimchi, R.; Bakhanashvili, M.; Salzberg, S. Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon. J. Virol. 1981, 40, 830-838.
3. Aboud, M.; Malik, Z.; Bari, S.; Kimchi, R.; Hassan, Y.; Salzberg, S. Effect of interferon on the formation and release of intracellular virions in NIH/3T3 cells chronically infected with Moloney murine leukemia virus. J. Interferon Res. 1983, 3, 33-44.
4. Agy, M.B.; Acker, R.L.; Sherbert, C.H.; Katze, M.G. Interferon treatment inhibits virus replication in HIV-1-and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins. Virology 1995, 214, 379-386.
5. Almeida, M.; Cordero, M.; Almeida, J.; Orfao, A. Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection. AIDS 2005, 19, 261-271.
6. Alsharifi, M.; Müllbacher, A.; Regner, M. Interferon type I responses in primary and secondary infections. Immunol. Cell. Biol. 2008, 86, 239-245.
7. Andrieu, M.; Chassin, D.; Desoutter, J.F.; Bouchaert, I.; Baillet, M.; Hanau, D.; Guillet, J.G.; Hosmalin, A. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes. AIDS Res. Hum. Retroviruses 2001, 17, 1365-1370.
8. Babé, L.M.; Unal, A.; Craik, C.S. Obstruction of HIV-1 particle release by interferon-α occurs before viral protease processing and is independent of envelope glycoprotein. J. Interferon Cytokine Res. 1997, 17, 287-93.
9. Baca-Regen L.; Heinzinger N.; Stevenson M.; Gendelman HE. A interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J. Virol. 1994, 68, 7559-7565.
10. Balachandran, S.; Kim, C.N.; Yeh, W.C.; Mak, T.W.; Bhalla, K.; Barber, G.N. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 1998, 17, 6888-6902.
11. Baldwin, S.L.; Powell, T.D.; Sellins, K.S.; Radecki, S.V.; Cohen, J.J.; Milhausen, M.J. The biological effects of five feline IFN-α subtypes. Vet. Immunol. Immunopathol. 2004, 99, 153-167.
12. Bandyopadhyay, SK.; Leonard, G.T. Jr.; Bandyopadhyay, T.; Stark, G.R.; Sen, G.C. Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. J. Biol. Chem. 1995, 270, 19624-9.
13. Barber, G.N. The interferons and cell death: guardians of the cell or accomplices of apoptosis? Semin. Cancer Biol. 2000, 10, 103-111.
14. Barron, M.A.; Blyveis., N.; Palmer, B.E.; MaWhinney, S.; Wilson, C.C. Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J. Infect. Dis. 2003, 187, 26-37
15. Battistini, A.; Marsili, G.; Sgarbanti, M.; Ensoli, B.; Hiscott, J. IRF regulation of HIV-1 long terminal repeat activity. J. Interferon Cytokine Res. 2002, 22, 27-37.
16. Bekisz, J.; Schmeisser, H.; Hernandez, J.; Goldman, ND.; Zoon, KC. Human interferons α, beta and omega. Growth Factors 2004, 22, 243-251.
17. Belardelli, F.; Ferrantini, M.; Proietti, E.; Kirkwood, J.M. Interferon-α in tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 2002, 13, 119-134.
18. Boasso, A.; Shearer, G.M. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin. Immunol. 2008, 126, 235-242.
19. Bolinger, C.; Boris-Lawrie, K. Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome. Retrovirology 2009, 6:8 (20 pp)
20. Boxus, M.; Twizere, J.C.; Legros, S.; Dewulf, J.F.; Kettmann, R.; Willems, L. The HTLV-1 Tax interactome. Retrovirology 2008, 5, 76.
21. Brown, D.A.; Rose, J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992, 68, 533-544.
22. Bushman, F.D. Targeting survival: integration site selection by retroviruses and LTRretrotransposons. Cell 2003, 115, 135-138.
23. Chaudhuri, A.; Yang, B.; Gendelman, H.E.; Persidsky, Y.; Kanmogne, G.D. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 2008, 111, 2062-2072.
24. Chawla-Sarkar, M.; Lindner, DJ.; Liu, Y.F.; Williams, B.R.; Sen, G.C.; Silverman, R.H.; Borden, E.C. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003, 8, 237-249.
25. Chehimi, J.; Campbell, D.E.; Azzoni, L.; Bacheller, D.; Papasavvas, E.; Jerandi, G.; Mounzer, K.; Kostman, J.; Trinchieri, G.; Montaner, L.J. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J. Immunol. 2002, 168, 4796-4801.
26. Clayette, P.; Martin, M.; Dereuddre-Bosquet, N.; Tournay, V.; Gras, G.; Martal, J.; Dormont, D. IFN-tau, a new interferon type I with antiretroviral activity. Pathol. Biol. (Paris) 1999, 47, 553-559.
27. Coccia, E.M.; Krust, B.; Hovanessian, A.G. Specific inhibition of viral protein synthesis in HIVinfected cells in response to interferon treatment. J. Biol. Chem. 1994, 269, 23087-23094.
28. Collado, V.M.; Gómez-Lucía, E.; Tejerizo, G.; Miró, G.; Escolar, E.; Martín, S.; Doménech, A. Effect of type I interferons on the expression of feline leukaemia virus. Vet. Microbiol. 2007, 123, 180-186.
29. Collado, V.M.; Doménech, A.; Ballesteros, N.A.; Ramos, P.; Miró, G.; Gómez-Lucía, E. Efecto in vitro del interferón de tipo I en la expresión del virus de la inmunodeficiencia felina (FIV). In Proceedings of the Xth National Virology Congress, Salamanca, Spain, June 2009; p. 274.
30. Collado, unpublished results.
31. Colonna, M.; Krug, A.; Cella, M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 2002, 14, 373-379.
32. Czarniecki, C.W.; Sreevalsan, T.; Friedman, R.M.; Panet, A. Dissociation of interferon effects on murine leukemia virus and encephalomyocarditis virus replication in mouse cells. J. Virol. 1981, 37, 827-831
33. de Mari, K.; Maynard, L.; Sanquer, A.; Lebreux, B.; Eun, H.M. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J. Vet. Intern. Med. 2004, 18, 477-478.
34. de Parseval, A; Elder, J.H. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J. Virol. 1999, 73, 608-617.
35. Dereuddre-Bosquet, N.; Clayette, P.; Martin, M.; Mabondzo, A.; Frétier, P.; Gras, G.; Martal, J.; Dormont, D. Anti-HIV potential of a new interferon, interferon-tau (trophoblastin). J. Acquir. ImmuneDefic. Syndr. Hum. Retrovirol. 1996, 11, 241-246.
36. Dianzani, F.; Castilletti, C.; Gentile, M.; Gelderblom, H.R.; Frezza, F.; Capobianchi, M.R. Effects of IFN α on late stages of HIV-1 replication cycle. Biochimie 1998, 80, 745-754.
37. Diebold, S.S.; Montoya, M.; Unger, H.; Alexopoulou, L.; Roy, P.; Haswell, L.E.; Al-Shamkhani, A.; Flavell, R.; Borrow, P.; Reis e Sousa, C. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003, 424, 324-328.
38. Diop, O.M.; Ploquin, M.J.; Mortara, L.; Faye, A.; Jacquelin, B.; Kunkel, D.; Lebon, P.; Butor, C.; Hosmalin, A.; Barré-Sinoussi, F.; Müller-Trutwin, M.C. Plasmacytoid dendritic cell dynamics and α interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J. Virol. 2008, 82, 5145-5152.
39. Donaghy, H.; Pozniak, A.; Gazzard, B.; Qazi, N.; Gilmour, J.; Gotch, F.; Patterson, S. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001, 98, 2574-2576.
40. Donaghy, H.; Gazzard, B.; Gotch, F.; Patterson, S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 2003, 101, 4505-4511.
41. Endo-Munoz, L.; Warby, T.; Harrich, D.; McMillan, NA. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription. Virol. J. 2005, 2:17. Pp 13.
42. Estaquier, J.; Idziorek, T.; de Bels, F.; Barré-Sinoussi, F.; Hurtrel, B.; Aubertin, A.M.; Venet, A.; Mehtali, M.; Muchmore, E.; Michel, P.; Mouton, Y.; Girard, M.; Ameisen, J.C. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc. Natl. Acad. Sci. USA 1994, 91, 9431-9435.
43. Eyster, M.E.; Goedert, J.J.; Poon, M.C.; Preble, O.T. Acid-labile α interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. N. Engl. J. Med. 1983, 309, 583-586.
44. Feldman, S.; Stein, D.; Amrute, S.; Denny, T.; Garcia, Z.; Kloser, P.; Sun, Y.; Megjugorac, N.; Fitzgerald-Bocarsly, P. Decreased interferon-α production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin. Immunol. 2001, 101, 201-210.
45. Feng, X.; Ratner, L. Human T-cell leukemia virus type 1 blunts signaling by interferon α. Virology 2008, 374, 210-216.
46. Feng, X.; Heyden, N.V.; Ratner, L. A interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J. Virol. 2003, 77, 13389-13395.
47. Finke, J. S.; Shodell, M.; Shah, K.; Siegal, F. P.; Steinman, R.M. Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy. J. Clin. Immunol. 2004, 24, 647-652.
48. Fiorentini, S.; Riboldi, E.; Facchetti, F.; Avolio, M.; Fabbri, M.; Tosti, G.; Becker, PD.; Guzman, CA.; Sozzani, S.; Caruso, A. HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype. Proc. Natl. Acad. Sci. USA 2008, 105, 3867-3872.
49. Fitzgerald-Bocarsly, P.; Feng, D. The role of type I interferon production by dendritic cells in host defense. Biochimie 2007, 89, 843-855.
50. Gabriele, L.; Ozato, K. The role of the interferon regulatory factor (IRF) family in dendritic cell development and function. Cytokine Growth Factor Rev. 2007, 18, 503-510.
51. Gendelman, H.E.; Baca, L.M.; Turpin, J.; Kalter, D.C.; Hansen, B.; Orenstein, J.M.; Dieffenbach, C.W.; Friedman, R.M.; Meltzer, M.S. Regulation of HIV replication in infected monocytes by IFN-α. Mechanisms for viral restriction. J. Immunol. 1990, 145, 2669-2676.
52. Gerlach, N.; Schimmer, S.; Weiss, S.; Kalinke, U.; Dittmer, U. Effects of type I interferons on Friend retrovirus infection. J. Virol. 2006, 80, 3438-3444.
53. Gomez-Lucia, E.; Tejerizo, G.; Doménech, A. Effect of steroid hormones on retroviruses. In Oncogenic Viruses. Research Trends; Johannes, L.T.; Nova Biomedical: New York, USA, 2007; pp. 163-191.
54. Goodbourn, S.; Didcock, L.; Randall, R.E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 2000, 81, 2341-2364.
55. Göttlinger, H.G.; Dorfman, T.; Sodroski, J.G.; Haseltine, W.A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA 1991, 88, 3195-3199.
56. Haller, O.; Kochs, G.; Weber, F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344, 119-130.
57. Hansen, B.D.; Nara, P.L.; Maheshwari, R.K.; Sidhu, G.S.; Bernbaum, J.G.; Hoekzema, D.; Meltzer, M.S.; Gendelman, H.E. Loss of infectivity by progeny virus from α interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120. J. Virol. 1992, 66, 7543-7548.
58. Hardy, A.W.; Graham, D.R.; Shearer, G.M.; Herbeuval, J.P. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α. Proc. Natl. Acad. Sci. U S A. 2007, 104, 17453-17458.
59. Haupt, S.; Donhauser, N.; Chaipan, C.; Schuster, P.; Puffer, B.; Daniels, R.S.; Greenough, T.C.; Kirchhoff, F.; Schmidt, B. CD4 binding affinity determines human immunodeficiency virus type 1-induced α interferon production in plasmacytoid dendritic cells. J. Virol. 2008, 82, 8900-8905.
60. Herbeuval, J.P.; Shearer, G.M. HIV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol. 2007, 123, 121-128.
61. Herbeuval, J.P.; Grivel, J.C.; Boasso, A.; Hardy, A.W.; Chougnet, C.; Dolan, M.J.; Yagita, H.; Lifson, J.D.; Shearer, G.M. CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood 2005, 106, 3524-3531.
62. Herbeuval, J.P.; Nilsson, J.; Boasso, A.; Hardy, A.W.; Kruhlak, M.J.; Anderson, S.A.; Dolan, M.J.; Dy, M.; Andersson, J.; Shearer, G.M. Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc. Natl. Acad. Sci. U S A. 2006, 103, 7000-7005.
63. Hishizawa, M.; Imada, K.; Kitawaki, T.; Ueda, M.; Kadowaki, N.; Uchiyama, T. Depletion and impaired interferon-α-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. Br. J. Haematol. 2004, 125, 568-575.
64. Honda, K.; Yanai, H.; Negishi, H.; Asagiri, M.; Sato, M.; Mizutani, T.; Shimada, N.; Ohba, Y.; Takaoka, A.; Yoshida, N.; Taniguchi, T. IRF-7 is the master regulator of type-I interferondependent immune responses. Nature 2005, 434, 772-777.
65. Honda, K.; Yanai, H.; Takaoka, A.; Taniguchi, T. Regulation of the type I IFN induction: a current view. Int. Immunol. 2005, 17, 1367-1378.
66. Hong, H.S.; Bhatnagar, N.; Ballmaier, M.; Schubert, U.; Henklein, P.; Volgmann, T.; Heiken, H.; Schmidt, R.E.; Meyer-Olson, D. Exogenous HIV-1 Vpr disrupts IFN-α response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay. Immunol. Lett. 2009, 125, 100-104.
67. Huthoff, H.; Towers, G.J. Restriction of retroviral replication by APOBEC3G/F and TRIM5α. Trends Microbiol. 2008, 16, 612-619.
68. Imbeault, M.; Ouellet, M.; Tremblay, M.J. Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells. Retrovirology 2009, 6:5, pp. 14.
69. Jameson, P.; Essex, M. Inhibition of feline leukemia virus replication by human leukocyte interferon. Antiviral Res. 1983, 3, 115-120.
70. Jarrett, O. Strategies of retrovirus survival in the cat. Vet. Microbiol. 1999, 69, 99-107.
71. Juste, R.A.; Ott, T.L.; Kwang, J.; Bazer, F.W.; de la Concha-Bermejillo, A. Effects of recombinant interferon-tau on ovine lentivirus replication. J. Interferon Cytokine Res. 1996, 16, 989-994.
72. Juste, R.A.; Ott, T.L.; Kwang, J.; Bazer, F.W.; de La Concha-Bermejillo, A. Effects of recombinant ovine interferon-tau on ovine lentivirus replication and progression of disease. J. Gen. Virol. 2000, 81, 525-532.
73. Kamga, I.; Kahi, S.; Develioglu, L.; Lichtner, M.; Marañón, C.; Deveau, C.; Meyer, L.; Goujard, C.; Lebon, P.; Sinet, M.; Hosmalin, A. Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. J. Infect. Dis. 2005, 192, 303-310.
74. Karpov, A.V. Endogenous and exogenous interferons in HIV-infection. Eur. J. Med. Res. 2001, 6, 507-524.
75. Kawaguchi, Y; Norimine, J; Miyazawa, T; Kai, C; Mikami, T. Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1. Virology 1992, 190, 465-468.
76. Keir, M.E.; Stoddart, C.A.; Linquist-Stepps, V.; Moreno, M.E.; McCune, J.M. IFN-α secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus. J. Immunol. 2002, 168, 325-331.
77. Keir, M.E.; Rosenberg, M.G.; Sandberg, J.K.; Jordan, K.A.; Wiznia, A.; Nixon, D.F.; Stoddart, C.A.; McCune, J.M. Generation of CD3+CD8low thymocytes in the HIV type 1-infected thymus. J. Immunol. 2002, 169, 2788-2796.
78. Kiermer, V.; Van Lint, C.; Briclet, D.; Vanhulle, C.; Kettmann, R.; Verdin, E.; Burny, A.; Droogmans, L. An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression. J. Virol. 1998, 72, 5526-5534.
79. Kinpara, S.; Hasegawa, A.; Utsunomiya, A.; Nishitsuji, H.; Furukawa, H.; Masuda, T.; Kannagi, M. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon. J. Virol. 2009, 83, 5101-5108.
80. Kohara, J.; Yokomizo, Y. In vitro and in vivo effects of recombinant bovine interferon-tau on bovine leukemia virus. J. Vet. Med. Sci. 2007, 69, 15-19.
81. Kornbluth, R.S.; Oh, P.S.; Munis, J.R.; Cleveland, P.H.; Richman, D.D. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 1989, 169, 1137-1151.
82. Künzi, M.S.; Pitha, P.M. Role of interferon-stimulated gene ISG-15 in the interferon-omegamediated inhibition of human immunodeficiency virus replication. J. Interferon Cytokine Res. 1996, 16, 919-927.
83. Künzi, M.S.; Farzadegan, H.; Margolick, J.B.; Vlahov, D.; Pitha, P.M. Identification of human immunodeficiency virus primary isolates resistant to interferon-α and correlation of prevalence to disease progression. J. Infect. Dis. 1995, 171, 822-828.
84. Lehner, T.; Wang, Y.; Pido-Lopez, J.; Whittall, T.; Bergmeier, L.A.; Babaahmady, K. The emerging role of innate immunity in protection against HIV-1 infection. Vaccine 2008, 26, 2997-3001.
85. Levy, D.E. Physiological significance of STAT proteins: investigations through gene disruption in vivo. Cell. Mol. Life Sci. 1999, 55, 1559-1567.
86. Levy, J.A.; Scott, I.; Mackewicz, C. Protection from HIV/AIDS: the importance of innate immunity. Clin. Immunol. 2003, 108, 167-174.
87. Lopez, C.; Fitzgerald, P.A.; Siegal, F.P. Severe acquired immune deficiency syndrome in male homosexuals: diminished capacity to make interferon-α in vitro associated with severe opportunistic infections. J. Infect. Dis. 1983, 148, 962-966.
88. Luo, C.; Wang, K.; Liu de, Q.; Li, Y.; Zhao, Q.S. The functional roles of lipid rafts in T cell activation.; immune diseases and HIV infection and prevention. Cell. Mol. Immunol. 2008, 5, 1-7.
89. Macchi, B.; Faraoni, I.; Mastino, A.; D'Onofrio, C.; Romeo, G.; Bonmassar, E. Protective effect of interferon beta on human T cell leukaemia virus type I infection of CD4+ T cells isolated from human cord blood. Cancer Immunol. Immunother. 1993, 37, 97-104.
90. Mandl, J.N.; Barry, A.P.; Vanderford, T.H.; Kozyr, N.; Chavan, R.; Klucking, S.; Barrat, F.J.; Coffman, R.L.; Staprans, S.I.; Feinberg, M.B. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med. 2008, 14, 1077-1087.
91. Maneglier, B.; Rogez-Kreuz, C.; Dereuddre-Bosquet, N.; Martal, J.; Devillier, P.; Dormont, D.; Clayette, P. Anti-HIV effects of IFN-tau in human macrophages: role of cellular antiviral factors and interleukin-6. Pathol. Biol. (Paris) 2008, 56, 492-503.
92. Mangino, G.; Percario, Z.A.; Fiorucci, G.; Vaccari, G.; Manrique, S.; Romeo, G.; Federico, M.; Geyer, M.; Affabris, E. In vitro treatment of human monocytes/macrophages with myristoylated recombinant Nef of human immunodeficiency virus type 1 leads to the activation of mitogenactivated protein kinases, IkappaB kinases, and interferon regulatory factor 3 and to the release of beta interferon. J. Virol. 2007, 81, 2777-2791.
93. Marchetti, M.; Monier, M.N.; Fradagrada, A.; Mitchell, K.; Baychelier, F.; Eid, P.; Johannes, L.; Lamaze, C. Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. Mol. Biol. Cell. 2006, 17, 2896-2909.
94. Marcondes, M.C.; Flynn, C.; Huitron-Rezendiz, S.; Watry, D.D.; Zandonatti, M.; Fox, H.S. Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys. AIDS 2009, 23, 1187-1195.
95. Marié, I.; Durbin, J.E.; Levy, D.E. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998, 17, 6660-6669.
96. Marsili, G.; Borsetti, A.; Sgarbanti, M.; Remoli, A.L.; Ridolfi, B.; Stellacci, E.; Ensoli, B.; Battistini, A. On the role of interferon regulatory factors in HIV-1 replication. Ann. N Y Acad. Sci. 2003, 1010, 29-42.
97. Meylan, P.R.; Guatelli, J.C.; Munis, J.R.; Richman, D.D.; Kornbluth, R.S. Mechanisms for the inhibition of HIV replication by interferons-α,-beta, and-gamma in primary human macrophages. Virology 1993, 193, 138-148.
98. Mogensen, K.E.; Lewerenz, M.; Reboul, J.; Lutfalla, G.; Uzé, G. The type I interferon receptor: structure, function, and evolution of a family business. J. Interferon Cytokine Res. 1999, 19, 1069-1098.
99. Munier, S.; Delcroix-Genête, D.; Carthagéna, L.; Gumez, A.; Hazan, U. Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency. Retrovirology 2005, 2, 73.
100. Murphy, F.A.; Gibbs, E.P.J.; Horzinek, M.C.; Studdert, M.J. Retroviridae. In Veterinary Virology 3rd Ed. Academic Press: San Diego, USA; 1999; pp 363-389.
101. Niermann, G.L.; Buehring, G.C. Hormone regulation of bovine leukemia virus via the long terminal repeat. Virology 1997, 239, 249-258.
102. Oka, T.; Ohtsuki, Y.; Sonobe, H.; Furihata, M.; Miyoshi, I. Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I). Arch. Virol. 1990, 115, 63-73.
103. Okumura, A.; Lu, G.; Pitha-Rowe, I.; Pitha, P.M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U S A. 2006, 103, 1440-1445.
104. Pacanowski, J.; Kahi, S.; Baillet, M.; Lebon, P.; Deveau, C.; Goujard, C.; Meyer, L.; Oksenhendler, E.; Sinet, M.; Hosmalin, A. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 2001, 98, 3016-3021.
105. Pacanowski, J.; Develioglu, L.; Kamga, I.; Sinet, M.; Desvarieux, M.; Girard, P. M.; Hosmalin, A. Early plasmacytoid dendritic cell changes predict plasma HIV load rebound during primary infection. J. Infect. Dis. 2004, 190, 1889-1892.
106. Pedretti, E.; Passeri, B.; Amadori, M.; Isola, P.; Di Pede, P.; Telera, A.; Vescovini, R.; Quintavalla, F.; Pistello, M. Low-dose interferon-α treatment for feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 2006, 109, 245-254.
107. Pestka, S.; Krause, C.D.; Walter, M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 2004, 202, 8-32.
108. Poli, G.; Orenstein, J.M.; Kinte, r A.; Folks, T.M.; Fauci, A.S. Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines. Science 1989, 244, 575-577.
109. Pontzer, C.H.; Yamamoto, J.K.; Bazer, F.W.; Ott, T.L.; Johnson, H.M. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau. J. Immunol. 1997, 158, 4351-4357.
110. Quaranta, M.G.; Mattioli, B.; Giordani, L.; Viora, M. HIV-1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion. FASEB J. 2004, 18, 1459-1461.
111. Ramji, D. P; Foka, P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 2002, 365, 561-575.
112. Randall, R.E.; Goodbourn, S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89, 1-47.
113. Rho, M.B.; Wesselingh, S.; Glass, J.D.; McArthur, J.C.; Choi, S.; Griffin, J.; Tyor, W.R. A potential role for interferon-α in the pathogenesis of HIV-associated dementia. Brain Behav. Immun. 1995, 9, 366-377.
114. Rogez, C.; Martin, M.; Dereuddre-Bosquet, N.; Martal, J.; Dormont, D.; Clayette, P. Anti-human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta-chemokines. J. Virol. 2003, 77, 12914-12920.
115. Rogez-Kreuz, C.; Manéglier, B.; Martin, M.; Dereuddre-Bosquet, N.; Martal, J.; Dormont, D.; Clayette, P. Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-tau in human macrophages. Int. Immunol. 2005, 17, 1047-1057.
116. Rossol, S.; Voth, R.; Laubenstein, H.P.; Müller, W.E.; Schröder, H.C.; Meyer zum Büschenfelde, K.H.; Hess, G. Interferon production in patients infected with HIV-1. J. Infect. Dis. 1989, 159, 815-821.
117. Saito, M.; Nakagawa, M.; Kaseda, S.; Matsuzaki, T.; Jonosono, M.; Eiraku, N.; Kubota, R.; Takenouchi, N.; Nagai, M.; Furukawa, Y.; Usuku, K.; Izumo, S.; Osame, M. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-α therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Infect. Dis. 2004, 189, 29-40.
118. Sakuma, R.; Mael, A.A.; Ikeda, Y. A interferon enhances TRIM5α-mediated antiviral activities in human and rhesus monkey cells. J. Virol. 2007, 81, 10201-10206.
119. Samuel, C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14, 778-809.
120. Sas, A.R.; Bimonte-Nelson, H.A.; Tyor, W.R. Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-α in the brain. AIDS 2007, 21, 2151-2159.
121. Sas, A.R.; Bimonte-Nelson, H.; Smothers, C.T.; Woodward, J.; Tyor, W.R. Interferon-α causes neuronal dysfunction in encephalitis. J. Neurosci. 2009, 29, 3948-3955.
122. Schmidt, B.; Ashlock, B. M.; Foster, H.; Fujimura, S. H.; Levy, J. A. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology 2005, 343, 256-266.
123. Severa, M.; Fitzgerald, K.A. TLR-mediated activation of type I IFN during antiviral immune responses: fighting the battle to win the war. Curr. Top. Microbiol. Immunol. 2007, 316, 167-192.
124. Sgarbanti, M.; Borsetti, A.; Moscufo, N.; Bellocchi, MC.; Ridolfi, B.; Nappi, F.; Marsili, G.; Marziali, G.; Coccia, EM.; Ensoli, B.; Battistini, A. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J. Exp. Med. 2002, 195, 1359-1370.
125. Sgarbanti, M.; Marsili, G.; Remoli, A.L.; Ridolfi, B.; Stellacci, E.; Borsetti, A.; Ensoli, B.; Battistini, A. Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation. Ann. N Y Acad. Sci. 2004, 1030, 187-195.
126. Shirazi, Y.; Pitha, P.M. A interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J. Virol. 1992, 66, 1321-1328.
127. Shirazi, Y.; Pitha, P.M. Interferon α-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 1993, 193, 303-312.
128. Short, J.A.L. Viral evasion of interferon stimulated genes. Bioscience Horizons 2009, 2, 212-224.
129. Singh, B.; Ott, T.L.; Bazer, F.W.; de la Concha-Bermejillo, A. Phenotypic and ultrastructural characteristics of bronchoalveolar lavage cells of lentivirus-infected lambs treated with recombinant ovine IFN-tau. J. Interferon Cytokine Res. 2001, 21, 677-686.
130. Skalka, A.M.; Katz, R.A. Retroviral DNA integration and the DNA damage response. Cell Death Differ. 2005, Suppl 1, 971-978.
131. Smith, M.S.; Thresher, R.J.; Pagano, J.S. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by α interferon. Antimicrob. Agents Chemother. 1991, 35, 62-67.
132. Soumelis, V.; Scott, I.; Gheyas, F.; Bouhour, D.; Cozon, G.; Cotte, L.; Huang, L.; Levy, J.A.; Liu, Y.J. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 2001, 98, 906-912.
133. Soumelis, V.; Scott, I.; Liu, Y.J.; Levy, J. Natural type 1 interferon producing cells in HIV infection. Hum. Immunol. 2002, 63, 1206-1212.
134. Sparger, E.E.; Shacklett, B.L.; Renshaw-Gegg, L.; Barry, P.A.; Pedersen, N.C.; Elder, J.H.; Luciw, P.A. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 1992, 187, 165-177.
135. Stark, G.R.; Kerr, I.M.; Williams, B.R.; Silverman, R.H.; Schreiber, R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67, 227-264.
136. Tanabe, T.; Yamamoto, J.K. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma. J. Interferon Cytokine Res. 2001, 21, 1039-46.
137. Taylor, M.D.; Korth, M.J.; Katze, M.G. Interferon treatment inhibits the replication of simian immunodeficiency virus at an early stage: evidence for a block between attachment and reverse transcription. Virology 1998, 241, 156-162.
138. Thompson, A.J.V.; Locarnini, S.A. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol. Cell. Biol. 2007, 85, 435-445.
139. Thompson, F.J.; Elder, J.; Neil, J.C. Cis-and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat. J. Gen. Virol. 1994, 75, 545-554.
140. Tilton, J.C.; Johnson, A.J.; Luskin, M.R.; Manion, M.M.; Yang, J.; Adelsberger, J.W.; Lempicki, R.A.; Hallahan, C.W.; McLaughlin, M.; Mican, J.M.; Metcalf, J.A.; Iyasere, C.; Connors, M. Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J. Virol. 2006, 80, 11486-11497.
141. Tilton, J.C.; Manion, M.M.; Luskin, M.R.; Johnson, A.J.; Patamawenu, A.A.; Hallahan, C.W.; Cogliano-Shutta, N.A.; Mican, J.M.; Davey, R.T. Jr.; Kottilil, S.; Lifson, J.D.; Metcalf, J.A.; Lempicki, R.A.; Connors, M. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished α interferon production in vitro. J. Virol. 2008, 82, 3997-4006.
142. Tsukahara, T.; Kim, S.; Taylor, M.W. REFINEMENT: a search framework for the identification of interferon-responsive elements in DNA sequences--a case study with ISRE and GAS. Comput. Biol. Chem. 2006, 30, 134-147.
143. Uematsu, S.; Akira, S. Toll-like receptors and type I interferons. J. Biol. Chem. 2007, 282, 15319-15324.
144. Van Lint, C.; Amella, C.A.; Emiliani, S.; John, M.; Jie, T.; Verdin, E. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol. 1997, 71, 6113-6127.
145. Vieillard, V.; Costagliola, D.; Simon, A.; Debré, P; French Asymptomatiques à Long Terme (ALT) Study Group. Specific adaptive humoral response against a gp41 motif inhibits CD4 Tcell sensitivity to NK lysis during HIV-1 infection. AIDS 2006, 20, 1795-1804.
146. Williams, B.R. Transcriptional regulation of interferon-stimulated genes. Eur. J. Biochem. 1991, 200, 1-11.
147. Yamamoto, J.K.; Ho, E.; Pedersen, N.C. A feline retrovirus induced T-lymphoblastoid cell-line that produces an atypical α type of interferon. Vet. Immunol. Immunopathol. 1986, 11, 1-19.
148. Yonezawa, A.; Morita, R.; Takaori-Kondo, A.; Kadowaki, N.; Kitawaki, T.; Hori, T.; Uchiyama, T. Natural α interferon-producing cells respond to human immunodeficiency virus type 1 with α interferon production and maturation into dendritic cells. J. Virol. 2003, 77, 3777-3784.
149. Zeidner, N.S.; Myles, M.H.; Mathiason-DuBard, C.K.; Dreitz, M.J.; Mullins, J.I.; Hoover, E.A. A interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome. Antimicrob. Agents Chemother. 1990, 34, 1749-1756.
150. Zhang, J.; Yamada, O.; Kawagishi, K.; Araki, H.; Yamaoka, S.; Hattori, T.; Shimotohno, K. Human T-cell leukemia virus type 1 Tax modulates interferon-α signal transduction through competitive usage of the coactivator CBP/p300. Virology 2008, 379, 306-313.